Japan Medical Cannabis Market, by Distribution Channel

Growth Outlook

• The Japan Medical Cannabis Market, by Distribution Channel market is on a steady long-term growth path. Segment value stands at roughly USD 2 Mn in 2026 and is projected to reach USD 3 Mn by 2027 — a gain of about 29% over the forecast period, translating to a CAGR in the double digits.
• What the regional split looks like (2026): Hospital pharmacy leads, holding roughly 56% of segment value — the single largest regional share. Retail Pharamcy is the second-largest contributor. Online Pharmacy make up the remainder, in descending order.
• By 2027, Hospital pharmacy alone is expected to reach USD 2 Mn, with Retail Pharamcy at USD 1 Mn.

Market Dynamics

The medical cannabis market in Japan is garnering increasing attention as the country considers potential legalization for medicinal purposes. However, the distribution channels that will be used to provide medical cannabis to patients are still largely uncertain.

On one hand, there is the possibility of utilizing traditional pharmacies as distribution channels for medical cannabis. This option would offer patients a familiar and trusted source for medication, as well as a regulated and controlled system for dispensing cannabis. Pharmacies would also be able to provide dosage guidance and monitor patient usage to ensure safe and effective treatment.

On the other hand, there is also the possibility of implementing a patient-driven distribution model, similar to the one used for traditional medical marijuana in countries like the United States and Canada. In this model, patients would be able to obtain medical cannabis directly from licensed producers, either by picking it up at designated dispensaries or through delivery services. This option offers patients more convenience and potentially lower costs, as they would not have to go through a secondary source for their medication.

Another distribution channel that has been proposed for the medical cannabis market in Japan is hospitals. This model would allow patients to obtain medical cannabis through their healthcare providers, who would be responsible for prescribing and monitoring its usage. This option would ensure proper medical supervision and oversight, but could also create challenges in terms of availability and accessibility for patients.

Additionally, there is also the potential for online distribution channels to play a role in the medical cannabis market in Japan. Patients could order their medication from licensed online dispensaries, providing them with convenience and potentially larger product selection. However, this option would also require strict regulations and oversight to prevent misuse or illegal distribution.

The choice of distribution channels for medical cannabis in Japan will ultimately depend on government regulations and policies surrounding its legalization. Whichever channels are chosen, it is crucial for them to prioritize patient safety and access to affordable medication. As the medical cannabis market continues to evolve in Japan, it will be important to continually assess and improve distribution channels in order to provide the best possible care for patients in need.